Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401980
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-05-02
Brief Title:
Darolutamide in Metastatic Castration-Resistant Prostate Cancer mCRPC
Sponsor:
Swiss Group for Clinical Cancer Research
Organization:
Swiss Group for Clinical Cancer Research
Organization Data
Organization:
Swiss Group for Clinical Cancer Research
Class:
OTHER
Study ID:
SAKK 0823
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Swiss Group for Clinical Cancer Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None